Correlation of Glucose Metabolism with Cancer and Intervention with Traditional Chinese Medicine
Open Access
- 14 October 2022
- journal article
- review article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-17
Abstract
Cancer is a complex disease with several distinct characteristics, referred to as “cancer markers” one of which is metabolic reprogramming, which is a common feature that drives cancer progression. Over the last ten years, researchers have focused on the reprogramming of glucose metabolism in cancer. In cancer, the oxidative phosphorylation metabolic pathway is converted into the glycolytic pathway in order to meet the growth requirements of cancer cells, thereby creating a microenvironment that promotes cancer progression. The precise mechanism of glucose metabolism in cancer cells is still unknown, but it is thought to involve the aberrant levels of metabolic enzymes, the influence of the tumor microenvironment (TME), and the activation of tumor-promoting signaling pathways. It is suggested that glucose metabolism is strongly linked to cancer progression because it provides energy to cancer cells and interferes with antitumor drug pharmacodynamics. Therefore, it is critical to unravel the mechanism of glucose metabolism in tumors in order to gain a better understanding of tumorigenesis and to lay the groundwork for future research into the identification of novel diagnostic markers and therapeutic targets for cancer treatment. Traditional Chinese Medicine (TCM) has the characteristics of multiple targets, multiple components, and less toxic side effects and has unique advantages in tumor treatment. In recent years, researchers have found that a variety of Chinese medicine monomers and compound recipes play an antitumor role by interfering with the reprogramming of tumor metabolism. The underlying mechanisms of metabolism reprogramming of tumor cells and the role of TCM in regulating glucose metabolism are reviewed in this study, so as to provide a new idea for antitumor research in Chinese medicine.Keywords
Funding Information
- Key Research and Development Program of Hunan Province of China (2018SK2127)
This publication has 176 references indexed in Scilit:
- Oleanolic Acid Suppresses Migration and Invasion of Malignant Glioma Cells by Inactivating MAPK/ERK Signaling PathwayPLOS ONE, 2013
- The Tumor Microenvironment: A Pitch for Multiple PlayersFrontiers in Oncology, 2013
- Phosphofructokinase 1 Glycosylation Regulates Cell Growth and MetabolismScience, 2012
- Constitutive activation of breast tumor kinase accelerates cell migration and tumor growth in vivoOncogenesis, 2012
- Nuclear PKM2 regulates β-catenin transactivation upon EGFR activationNature, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- MYC-Induced Cancer Cell Energy Metabolism and Therapeutic OpportunitiesClinical Cancer Research, 2009
- Structural and Biochemical Studies of TIGAR (TP53-induced Glycolysis and Apoptosis Regulator)Journal of Biological Chemistry, 2009
- Cancer Cell Metabolism: Warburg and BeyondCell, 2008
- On the Origin of Cancer CellsScience, 1956